Cervarix

From Powerbase
Revision as of 12:38, 27 February 2009 by Iman Naji (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Background

Introduction Cervarix is a recently introduced recombinant bivalent HPV vaccine containing purified viruslike particles of the L1 capsid protein from HPV types 16 and 18 in a formulation with a novel and highly immunogenic proprietary adjuvant.

Biographical Information

History

Current activities

Views

Affiliations

People

Funding

Clients

Publications, Contact, Resources and Notes

Publications

Contact

Address:
Phone:
Email:
Website:

Resources

Notes